Neutral
Protara Therapeutics Inc stock (US87612E1064): Is its rare disease pipeline strong enough to unlock new upside?
Protara Therapeutics focuses on developing therapies for rare and specialty diseases with a lean pipeline centered on oncology and pediatric condition...